[Skip to Content]
[Skip to Content Landing]
Article
October 1986

Intravitreal Amikacin in the Treatment of Bacterial Endophthalmitis

Author Affiliations

From the Retina Service (Drs Talamo and D'Amico), the Howe Laboratory of Ophthalmology (Drs Talamo and D'Amico), and the Cornea Service (Dr Kenyon), the Massachusetts Eye and Ear Infirmary, and the Department of Ophthalmology, Harvard Medical School (Drs Talamo, D'Amico, and Kenyon), Boston.

Arch Ophthalmol. 1986;104(10):1483-1485. doi:10.1001/archopht.1986.01050220077030
Abstract

• Intravitreal administration of broadspectrum antibiotics is a widely accepted component of initial therapy for bacterial endophthalmitis. Four cases of cultureproved bacterial endophthalmitis are reported to demonstrate the safety of intravitreal administration of amikacin sulfate in conjunction with cephalosporins in patients. The benefits of using amikacin rather than gentamicin sulfate in intravitreal drug therapy are discussed, and a wider role for amikacin as the aminoglycoside of choice for initial intravitreal injection in presumed bacterial endophthalmitis is suggested.

References
1.
Smolin G, Tabbara K, Whitcher J: Infectious Diseases of the Eye , ed 1. Baltimore, Williams & Wilkins, 1984, pp 142-176.
2.
Baum J, Peyman GA, Barza M:  Intravitreal administration of antibiotic in the treatment of bacterial endophthalmitis: III. Consensus . Surv Ophthalmol 1982;26:204-206.Article
3.
Edson RS, Keys TF:  The aminoglycosides . Mayo Clin Proc 1983;58:99-102.
4.
Price KE, DeFuria MD, Pursiano TA:  Amikacin, an aminoglycoside with marked activity against antibiotic-resistant clinical isolates . J Infect Dis 1976;134:5249-6261.Article
5.
Weinstein RA, Nathan C, Gruensfelder R, et al:  Endemic aminoglycoside resistance in gram-negative bacilli: Epidemiology and mechanisms . J Infect Dis 1980;141:338-345.Article
6.
Davies J, Courvalin P:  Mechanisms of resistance to aminoglycosides . Am J Med 1977;62:868-872.Article
7.
Insler MS, Cavanaugh HD, Wilson LA:  Gentamicin-resistant Pseudomonas endophthalmitis after penetrating keratoplasty . Br J Ophthalmol 1985;69:189-191.Article
8.
Lambert SR, Stern WH:  Methicillin and gentamicin-resistant Staphylococcus epidermidis endophthalmitis after intraocular surgery . Am J Ophthalmol 1985;99:725-726.
9.
Moellering RC, Wennersten C, Kunz LJ, et al:  Resistance to gentamicin, tobramycin and amikacin among clinical isolates of bacteria . Am J Med 1977;62:873-881.Article
10.
D'Amico DJ, Libert J, Kenyon KR, et al:  Comparative toxicity of intravitreal aminoglycoside antibiotics . Am J Ophthalmol 1985;100:264-275.
11.
D'Amico DJ, Libert J, Kenyon KR, et al:  Retinal toxicity of intravitreal gentamicin . Invest Ophthalmol Vis Sci 1984;25:564-572.
12.
Peyman GA, Vastine DW, Raichand M:  Symposium: Postoperative endophthalmitis: Experimental aspects and their clinical application . Ophthalmology 1978;85:374-385.Article
13.
Forster RK, Abbott RL, Gelender H:  Management of infectious endophthalmitis . Ophthalmology 1980;87:313-319.Article
14.
Talamo JH, D'Amico DJ, Kenyon KR, et al:  Influence of aphakia and vitrectomy on experimental retinal toxicity of aminoglycoside antibiotics . Am J Ophthalmol 1985;100:840-847.
15.
Smith CR, Baughman KL, Edwards CQ, et al:  Controlled comparison of amikacin and gentamicin . N Engl J Med 1977;296:349-352.Article
16.
Zaske DE:  Pharmacokinetics of aminoglycosides , in Barnes WG, Hodges GR (eds): The Aminoglycoside Antibiotics: A Guide to Therapy . Boca Raton, Fla, CRC Press Inc, 1984, pp 45-87.
17.
Nelsen P, Peyman GA, Bennett TO:  BB-K8: A new aminoglycoside for intravitreal injection in bacterial endophthalmitis . Am J Ophthalmol 1974;78:82-89.
18.
Noone P, Pattison JR:  Therapeutic implications of interaction of gentamicin and penicillins . Lancet 1971;2:575-578.Article
19.
Riff LJ, Jackson GG:  Laboratory and clinical conditions for gentamicin inactivation by carbenicillin . Arch Intern Med 1972;130:887-891.Article
20.
Ervin FR, Bullock WE, Nuttall CE:  Inactivation of gentamicin by penicillins in patients with renal failure . Antimicrob Agents Chemother 1976;9:1004-1011.Article
21.
Hale DC, Jenkins R, Matsen JM:  In-vitro inactivation of aminoglycoside antibiotics by piperacillin and carbenicillin . Am J Clin Pathol 1980;74:316-319.
22.
Fluornoy DJ:  Factors influencing the inactivation of aminoglycosides by beta-lactams . Methods Find Exp Clin Pharmacol 1979;1:33-38.
23.
Wade JC, Smith CR, Petty BG, et al:  Cephalothin plus an aminoglycoside is more nephrotoxic than methicillin plus an aminoglycoside . Lancet 1978;2:604-606.Article
24.
Giamarello H, Metzikoff C, Papachristophorou S, et al:  Prospective comparative evaluation of gentamicin or gentamicin plus cephalothin in the production of nephrotoxicity in man . J Antimicrob Chemother 1979;5:581-590.Article
25.
Cobb LM, Forster RK:  The clearance of intravitreal gentamicin . Am J Ophthalmol 1981;92:59-62.
26.
Fisher JP, Civiletto SE, Forster RK:  Toxicity, efficacy, and clearance of intravitreally injected cefazolin . Arch Ophthalmol 1982;100:650& 652.Article
×